Abstract
Planned Interim Analysis of a Phase 2 Investigator-Initiated Trial of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have